MiniMed Go system

Worry less about figuring out the right correction dose with the only smart MDI system that continuously monitors, notifies you when a dose is needed, and calculates the suggested correction dose.1​

Good to go for ages 2 and up†

InPen with Instinct sensor

Get started today!

indicates a required field.

*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.

This form is for customers in the Unites States only. For more information about our products in your region please see our list of international locations.

This field is required.

HIPAA Marketing Authorization

MiniMed respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with MiniMed representatives and contractors who are assisting us with these activities.

I understand that this Authorization may permit MiniMed to contact me by text message, telephone, or email. With respect to text messages, I consent to receiving text messages at the phone number(s) submitted using automated technology from or on behalf of MiniMed, concerning the marketing, advertising, and/or offers of sale of MiniMed products, therapies, and services. I also certify that I am (a) age 18 or older and (b) authorizing and consenting to use of the information provided for MiniMed to contact me. My consent is not a condition for purchase. Airtime, message, and data rates may apply. I may opt out at any time by (i) texting "STOP" in reply to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into my MiniMed myHome profile and updating my communication preferences (www.diabetes.shop/communication).

Please note that this Authorization is optional, and you may refuse to opt in. If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLink™ Personal system, or other MiniMed products, mobile apps, or services.

This Authorization will expire ten (10) years from the date you submit it online. You may revoke it by:

Opting out will not affect actions already taken. Information disclosed may be re-disclosed and no longer protected by federal privacy standards. Questions? Contact Customer Service at 800-646-4633 or takecontrol@medtronic.com.
This field is required.

If you arrived on this site via a social media platform, by submitting this form you agree that MiniMed may share your visit to this site with that platform. This information may be used and/or re-disclosed by the originating site under their own privacy practices. See our Privacy Policy for more information. Click here to request information without submitting this form.

Thank you!

We've received your request – we'll be in touch with product information soon.

Oops!

Something went wrong. Please try again later.

Footnotes
† Products sold separately.

Reference

  1. Proper pairing, connectivity, and settings required. Talk to your healthcare professional before establishing and changing your settings. Ensure that all doses taken with InPen are logged in the app, that all doses taken with a device other than InPen are logged manually in the app, and that glucose and meal information entered into the dose calculator are current and accurate. Not doing so can result in incorrect dosing, hypoglycemia or hyperglycemia, and serious injury.

Important safety information: MiniMed Go system

The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see https://bit.ly/MiniMedRisks.